Dimension Vista® Flex® reagent cartridge CA15-3 10464344Recalls & reported problems
Siemens Healthcare Diagnostics Inc. · LOCI CA 15-3 Flex® reagent cartridge, 160 Tests · Class 2
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 4
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 00842768028526), received between Aug 4, 2022 and Aug 4, 2022 — classified as 4 malfunctions.
The most frequently reported specific device problem is “Low Test Results” (4 reports).
1 other recall cover devices cleared under the same FDA submission (K100344); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Low Test Results4
- High Test Results1
Patient problems
- No Clinical Signs, Symptoms or Conditions4
Recent adverse event reports
The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.
MalfunctionAug 4, 2022Low Test Results; Low Test Results
A CUSTOMER REPORTED THAT THEY NOTICED A SHIFT LOW IN RESULTS WHEN DOING PATIENT CORRELATIONS TESTING FOR CANCER ANTIGEN 15-3 (CA15-3) ON THE DIMENSION VISTA® 1500 SYSTEM, SERIAL NUMBER (B)(4). PATIENT CORRELATION SAMPLE RESULTS WERE NOT REPORTED TO PHYSICIANS. THERE ARE NO KNOWN REPORTS OF PATIENT INTERVENTION OR ADVERSE HEALTH CONSEQUENCES DUE TO THE REPORTED EVENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 15165540 ↗MalfunctionAug 4, 2022High Test Results; Low Test Results; High Test Results; Low Test Results
A CUSTOMER REPORTED THAT THEY NOTICED A SHIFT IN RESULTS WHEN DOING PATIENT CORRELATIONS TESTING FOR CANCER ANTIGEN 15-3 (CA15-3) ON THE DIMENSION VISTA® 500 SYSTEM, SERIAL NUMBER (B)(4). PATIENT CORRELATION SAMPLE RESULTS WERE NOT REPORTED TO PHYSICIANS. THERE ARE NO KNOWN REPORTS OF PATIENT INTERVENTION OR ADVERSE HEALTH CONSEQUENCES DUE TO THE REPORTED EVENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 15165518 ↗MalfunctionAug 4, 2022Low Test Results; Low Test Results
A CUSTOMER REPORTED THAT THEY NOTICED A SHIFT LOW IN RESULTS WHEN DOING PATIENT CORRELATIONS TESTING FOR CANCER ANTIGEN 15-3 (CA15-3) ON THE DIMENSION VISTA® 500 SYSTEM, SERIAL NUMBER: (B)(4). PATIENT CORRELATION SAMPLE RESULTS WERE NOT REPORTED TO PHYSICIANS. THERE ARE NO KNOWN REPORTS OF PATIENT INTERVENTION OR ADVERSE HEALTH CONSEQUENCES DUE TO THE REPORTED EVENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 15165497 ↗MalfunctionAug 4, 2022Low Test Results; Low Test Results
A CUSTOMER REPORTED THAT THEY NOTICED A SHIFT LOW IN RESULTS WHEN DOING PATIENT CORRELATIONS TESTING FOR CANCER ANTIGEN 15-3 (CA15-3) ON THE DIMENSION VISTA® 500 SYSTEM, SERIAL NUMBER (B)(4). PATIENT CORRELATION SAMPLE RESULTS WERE NOT REPORTED TO PHYSICIANS. THERE ARE NO KNOWN REPORTS OF PATIENT INTERVENTION OR ADVERSE HEALTH CONSEQUENCES DUE TO THE REPORTED EVENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 15165486 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under K100344. One submission often covers many models, so check the product and lot details in each record.
- Z-1648-2022 · Jul 18, 2022 · Open, ClassifiedDimension Vista LOCI CA 15-3 Flex reagent cartridge. In Vitro Diagnostic for the quantitative measurement of CA 15-3. Siemens Material Number (SMN)/Ref Catalog Number : 10464344
Other SYSTEM, TEST, IMMUNOLOGICAL, ANTIGEN, TUMOR devices
- ADVIA Centaur® CA 15-3® 10327620Siemens Healthcare Diagnostics Inc. · SYSTEM, TEST, IMMUNOLOGICAL, ANTIGEN, TUMOR14 reports
- Atellica IM BR 10995478Siemens Healthcare Diagnostics Inc. · SYSTEM, TEST, IMMUNOLOGICAL, ANTIGEN, TUMOR11 reports
- IMMULITE® 2000 Systems BRM BR-MA (CA15-3) 10380983Siemens Healthcare Diagnostics Products Ltd · SYSTEM, TEST, IMMUNOLOGICAL, ANTIGEN, TUMOR9 reports
- Atellica IM BR 10995477Siemens Healthcare Diagnostics Inc. · SYSTEM, TEST, IMMUNOLOGICAL, ANTIGEN, TUMOR8 reports
- ADVIA Centaur® BR +G 10333349Siemens Healthcare Diagnostics Inc. · SYSTEM, TEST, IMMUNOLOGICAL, ANTIGEN, TUMOR6 reports
- ADVIA Centaur® BR +G 10334837Siemens Healthcare Diagnostics Inc. · SYSTEM, TEST, IMMUNOLOGICAL, ANTIGEN, TUMOR4 reports
- Atellica IM CA 15-3 10995485Siemens Healthcare Diagnostics Inc. · SYSTEM, TEST, IMMUNOLOGICAL, ANTIGEN, TUMOR4 reports
- Atellica IM CA 15-3 10995486Siemens Healthcare Diagnostics Inc. · SYSTEM, TEST, IMMUNOLOGICAL, ANTIGEN, TUMOR3 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page